Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Revenue (Gross)Shares Outstanding
Ratios

Serina Therapeutics (SER) Cost of Revenue (2018 - 2023)

Historic Cost of Revenue for Serina Therapeutics (SER) over the last 6 years, with Q4 2023 value amounting to $1000.0.

  • Serina Therapeutics' Cost of Revenue changed 0.0% to $1000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $40000.0, marking a year-over-year increase of 20769.23%. This contributed to the annual value of $40000.0 for FY2023, which is 20769.23% up from last year.
  • Latest data reveals that Serina Therapeutics reported Cost of Revenue of $1000.0 as of Q4 2023, which was down 0.0% from $33000.0 recorded in Q3 2023.
  • In the past 5 years, Serina Therapeutics' Cost of Revenue ranged from a high of $79000.0 in Q4 2019 and a low of $1000.0 during Q1 2020
  • Its 5-year average for Cost of Revenue is $17100.0, with a median of $5000.0 in 2020.
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 112500.0% in 2019, then tumbled by 9841.27% in 2020.
  • Serina Therapeutics' Cost of Revenue (Quarter) stood at $79000.0 in 2019, then tumbled by 93.67% to $5000.0 in 2020, then crashed by 80.0% to $1000.0 in 2021, then changed by 0.0% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023.
  • Its last three reported values are $1000.0 in Q4 2023, $33000.0 for Q3 2023, and $5000.0 during Q2 2023.